| (Sr.) Regulatory Affairs Specialist |
Taipei |
Taiwan |
Development |
Innovative Medicines |
Research & Development |
20. Oktober 2024 |
| Senior Patient Safety Specialist |
Seoul |
Südkorea |
Development |
Innovative Medicines |
Research & Development |
20. Oktober 2024 |
| Clinical Label Manager |
Hyderabad (Office) |
Indien |
Development |
Innovative Medicines |
Research & Development |
20. Oktober 2024 |
| SSO Finance Specialist |
Shanghai (Shanghai) |
China |
Development |
Innovative Medicines |
Research & Development |
20. Oktober 2024 |
| Medical Scientific Liaison Manager, Immunologie (w/m/d), Gebiet: Sachsen |
Saxony (with Corpus Christi) (Novartis Pharma GmbH) |
Deutschland |
International |
Innovative Medicines |
Research & Development |
18. Oktober 2024 |
| Medical Advisor, Ophtha |
Shanghai (Shanghai) |
China |
International |
Innovative Medicines |
Research & Development |
18. Oktober 2024 |
| Medical Advisor, HEMA |
Shanghai (Shanghai) |
China |
International |
Innovative Medicines |
Research & Development |
18. Oktober 2024 |
| Senior Principal Clinical Data Standards Specialist |
Mumbai (Office) |
Indien |
Development |
Innovative Medicines |
Research & Development |
18. Oktober 2024 |
| Medical Safety and Processes Manager |
Barcelona Gran Vía |
Spanien |
Development |
Innovative Medicines |
Research & Development |
18. Oktober 2024 |
| Medical Education Manager, Breast Cancer |
Montreal |
Kanada |
International |
Innovative Medicines |
Research & Development |
18. Oktober 2024 |
| Study Start Up Senior Lead |
Dublin (Novartis Corporate Center (NOCC)) |
Irland |
Development |
Innovative Medicines |
Research & Development |
18. Oktober 2024 |
| RA Specialist |
Croatia |
Kroatien |
Development |
Innovative Medicines |
Research & Development |
18. Oktober 2024 |
| Senior Scientist I/II, Immunology– Immunogenicity and Mechanistic Immunology group |
Cambridge (USA) |
USA |
Biomedical Research |
Pharma Research |
Research & Development |
18. Oktober 2024 |
| Senior Scientist - Target Biology and Discovery |
Cambridge (USA) |
USA |
Biomedical Research |
Pharma Research |
Research & Development |
18. Oktober 2024 |
| Head Clinical Development Business Solutions |
East Hanover |
USA |
Development |
Innovative Medicines |
Research & Development |
18. Oktober 2024 |
| Oncology MSL |
INSURGENTES |
Mexiko |
International |
Innovative Medicines |
Research & Development |
18. Oktober 2024 |
| Chef, Éducation médicale - Cancer du sein |
Montreal |
Kanada |
International |
Innovative Medicines |
Research & Development |
18. Oktober 2024 |
| Associate Clinical Project Manager |
Head Office (Japan) (Pharmaceuticals) |
Japan |
Development |
Innovative Medicines |
Research & Development |
18. Oktober 2024 |
| (Sr.) Medical Advisor, LC |
Shanghai (Shanghai) |
China |
International |
Innovative Medicines |
Research & Development |
18. Oktober 2024 |
| Medical Science Liaison (MSL) ONC Solid Tumor Chicago Territory Remote |
Field Non-Sales (USA) |
USA |
US |
Innovative Medicines |
Research & Development |
17. Oktober 2024 |
| Senior Clinical Research Associate (Remote) |
Field Non-Sales (USA) |
USA |
Development |
Innovative Medicines |
Research & Development |
17. Oktober 2024 |
| Medical Science Liaison (MSL) Neuroscience Eastern PA, Northern NJ |
Field Non-Sales (USA) |
USA |
US |
Innovative Medicines |
Research & Development |
17. Oktober 2024 |
| Medical Science Liaison - Solid Tumors |
Bucuresti |
Rumänien |
International |
Innovative Medicines |
Research & Development |
17. Oktober 2024 |
| Country Patient Safety Head - France |
Paris Headquarter (Novartis Pharma S.A.S.) |
Frankreich |
Development |
Innovative Medicines |
Research & Development |
17. Oktober 2024 |
| Senior Expert Technical Development- Drug Product Project Lead |
East Hanover |
USA |
Development |
Innovative Medicines |
Research & Development |
17. Oktober 2024 |
| Vendor Alliance Lead Associate Director (Remote) |
East Hanover |
USA |
Development |
Innovative Medicines |
Research & Development |
17. Oktober 2024 |
| Global Program Safety Lead - Immunology |
Basel (City) |
Schweiz |
Development |
Innovative Medicines |
Research & Development |
17. Oktober 2024 |
| Global Program Safety Lead - Immunology |
London (The Westworks) |
Vereinigtes Königreich |
Development |
Sandoz |
Research & Development |
17. Oktober 2024 |
| Site Head – Biomedical Research India |
Hyderabad (Office) |
Indien |
Biomedical Research |
Pharma Research |
Research & Development |
17. Oktober 2024 |
| Strategy Director, Clinical Development |
Basel (City) |
Schweiz |
Development |
Innovative Medicines |
Research & Development |
17. Oktober 2024 |
| Director Science & Technology |
Basel (City) |
Schweiz |
Development |
Innovative Medicines |
Research & Development |
16. Oktober 2024 |
| Director, Development Unit Management |
Basel (City) |
Schweiz |
Development |
Innovative Medicines |
Research & Development |
16. Oktober 2024 |
| Research Scientist, Cell Pharmacology - CVM |
Cambridge (USA) |
USA |
Biomedical Research |
Pharma Research |
Research & Development |
16. Oktober 2024 |
| Senior Scientist I/II, Protein Engineering-REQ10019930 |
Cambridge (USA) |
USA |
Biomedical Research |
Pharma Research |
Research & Development |
16. Oktober 2024 |
| Senior Expert Science & Technology, Analytical Development |
East Hanover |
USA |
Development |
Innovative Medicines |
Research & Development |
16. Oktober 2024 |
| RA Operational Excellence Junior Associate – MEA |
Dubai |
Vereinigte Arabische Emirate |
Development |
Innovative Medicines |
Research & Development |
16. Oktober 2024 |
| Feasibility Manager |
INSURGENTES |
Mexiko |
Development |
Innovative Medicines |
Research & Development |
16. Oktober 2024 |
| Clinical Research Associate |
Field Force (Italy) |
Italien |
Development |
Innovative Medicines |
Research & Development |
16. Oktober 2024 |
| Japan Program Head (Neuroscience & GTx) |
Head Office (Japan) (Pharmaceuticals) |
Japan |
Development |
Innovative Medicines |
Research & Development |
16. Oktober 2024 |
| Japan Program Head (Immunology) |
Head Office (Japan) (Pharmaceuticals) |
Japan |
Development |
Innovative Medicines |
Research & Development |
16. Oktober 2024 |
| Manager, TRD Project management |
Head Office (Japan) (Pharmaceuticals) |
Japan |
Development |
Innovative Medicines |
Research & Development |
16. Oktober 2024 |
| Project Team Coordinator (Medical) (m/w/d) |
Nuremberg (Non-Sales Force) (Novartis Pharma GmbH) |
Deutschland |
International |
Innovative Medicines |
Research & Development |
15. Oktober 2024 |
| SSU Manager |
INSURGENTES |
Mexiko |
Development |
Innovative Medicines |
Research & Development |
15. Oktober 2024 |
| Senior Expert Technical Development - Cell Therapy Process Development Project Lead |
East Hanover |
USA |
Development |
Innovative Medicines |
Research & Development |
15. Oktober 2024 |
| Coordinator, Global Program Management and Portfolio Excellence |
INSURGENTES |
Mexiko |
Biomedical Research |
CTS |
Research & Development |
15. Oktober 2024 |
| Medical Lead |
Copenhagen |
Dänemark |
International |
Innovative Medicines |
Research & Development |
14. Oktober 2024 |
| QC Senior Scientist |
Ivrea |
Italien |
International |
Innovative Medicines |
Research & Development |
14. Oktober 2024 |
| Asset Strategy Lead - Automation (80-100%*) |
Basel (City) |
Schweiz |
Biomedical Research |
Pharma Research |
Research & Development |
14. Oktober 2024 |
| Associate Director, Vendor Alliance Lead |
London (The Westworks) |
Vereinigtes Königreich |
Development |
Innovative Medicines |
Research & Development |
14. Oktober 2024 |
| Clinical Pathologist, Preclinical Safety |
Cambridge (USA) |
USA |
Biomedical Research |
Pharma Research |
Research & Development |
14. Oktober 2024 |